Genetic polymorphism of CYP2D6 and lung cancer risk.

Shaw, G L; Falk, R T; Frame, J N; Weiffenbach, B; Nesbitt, J C; Pass, H I; Caporaso, N E; Moir, D T; Tucker, M A

Shaw, G L; Falk, R T; Frame, J N; Weiffenbach, B; Nesbitt, J C; Pass, H I; Caporaso, N E; Moir, D T; Tucker, M A.

Affiliation

Shaw GL; H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, Tampa 33612, USA.

Cancer Epidemiol Biomarkers Prev ; 7(3): 215-9, 1998 Mar.

Article in En | MEDLINE | ID: mdl-9521436

Subject(s)

Cytochrome P-450 CYP2D6/genetics; Lung Neoplasms/genetics; Polymorphism, Genetic; Adenocarcinoma/genetics; Adult; Aged; Alleles; Carcinoma, Small Cell/genetics; Carcinoma, Squamous Cell/genetics; Case-Control Studies; Female; Genetic Markers/genetics; Genotype; Germ-Line Mutation; Humans; Male; Middle Aged; Risk; Smoking/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Cytochrome P-450 CYP2D6 / Lung Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Epidemiol Biomarkers Prev Journal subject: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links